Hepatitis A historical perspective

Revision as of 05:56, 27 February 2021 by Nazmahanif (talk | contribs) (→‎Overview)
Jump to navigation Jump to search

Hepatitis Main Page

Hepatitis A

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis A from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Ultrasound

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Hepatitis A historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis A historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis A historical perspective

CDC on Hepatitis A historical perspective

Hepatitis A historical perspective in the news

Blogs on Hepatitis A historical perspective

Directions to Hospitals Treating Hepatitis A

Risk calculators and risk factors for Hepatitis A historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hepatitis A virus was first identified in 1973. It was classified as a separate disease from other types of hepatitis during World War II. However, its true prevalence and route of transmission would only be recognized later. During 1995-1996, the Food and Drug Administration (FDA) approved the inactivated hepatitis A vaccine. Consequently, hepatitis A became a disease that was not only common but also vaccine-preventable.

Historical Perspective

Hepatitis A virus was first identified in 1973. It was classified as a separate disease from other types of hepatitis during World War II. However, its true prevalence and route of transmission would only be recognized later.[1] During 1995-1996, the Food and Drug Administration (FDA) approved the inactivated hepatitis A vaccines. Consequently, hepatitis A became a disease that was not only common but also vaccine-preventable.

References

  1. Melnick JL (1995). "History and epidemiology of hepatitis A virus". J Infect Dis. 171 Suppl 1: S2–8. PMID [ 7876643 [ Check |pmid= value (help).

Template:WH Template:WS